Black Rock Inc. Kymera Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,155,429 shares of KYMR stock, worth $204 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,155,429

Previous 3,655,660 13.67%

Holding current value

$204 Million

Previous $147 Million 15.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$29.85 - $39.42 $14.9 Million - $19.7 Million	499,769 Added 13.67%	4,155,429 $124 Million
Q1 2024 May 10, 2024	BUY	$22.9 - $43.57 $2.04 Million - $3.88 Million	89,049 Added 2.5%	3,655,660 $147 Million
Q4 2023 Feb 13, 2024	BUY	$10.97 - $26.84 $2.29 Million - $5.6 Million	208,727 Added 6.22%	3,566,611 $90.8 Million
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $1.84 Million - $3.15 Million	132,038 Added 4.09%	3,357,884 $46.7 Million
Q2 2023 Aug 11, 2023	SELL	$22.4 - $34.92 $2.34 Million - $3.64 Million	-104,344 Reduced 3.13%	3,225,846 $74.2 Million
Q1 2023 May 12, 2023	SELL	$24.84 - $38.75 $117,021 - $182,551	-4,711 Reduced 0.14%	3,330,190 $98.7 Million
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $2.55 Million - $4.03 Million	130,219 Added 4.06%	3,334,901 $83.2 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $7.87 Million - $12.9 Million	376,248 Added 13.3%	3,204,682 $69.8 Million
Q2 2022 Aug 12, 2022	SELL	$14.13 - $42.55 $8.35 Million - $25.1 Million	-590,650 Reduced 17.28%	2,828,434 $55.7 Million
Q1 2022 May 12, 2022	BUY	$35.3 - $64.68 $760,503 - $1.39 Million	21,544 Added 0.63%	3,419,084 $145 Million
Q4 2021 Feb 10, 2022	BUY	$49.91 - $65.56 $17.8 Million - $23.4 Million	357,109 Added 11.75%	3,397,540 $216 Million
Q3 2021 Nov 09, 2021	BUY	$47.8 - $66.66 $28.3 Million - $39.5 Million	591,914 Added 24.17%	3,040,431 $179 Million
Q2 2021 Aug 11, 2021	BUY	$31.08 - $51.95 $76.1 Million - $127 Million	2,448,517 New	2,448,517 $119 Million

Others Institutions Holding KYMR

# of Institutions

160

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.68B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account